Hereditary non-polyposis colorectal cancer (Lynch syndrome ) is an apparently autosomal dominant condition characterised by an early age of onset (typically 40-45 years), an excess of proximal tumours and of metachronous disease, and a risk of other malignancies within the pedigree.' Although more common than familial polyposis coli, its prevalence and characteristic features have only rarely been described in population based studies. 2 If multiply affected families are to be recruited for genetic linkage studies or in the evaluation of surveillance programmes for those at highest risk, then ideally these patients should be representative ofthe general population ofsusceptibles in the community. Subjects referred to specialist family cancer clinics either because of an early age of onset or a noted familial risk may not reflect the characteristics of the majority of those in the community carrying an inherited susceptibility. 6 Recently, we estimated the contribution of Lynch syndrome to the total colorectal cancer burden to be between 1 and 2%,' a prevalence somewhat less than estimated elsewhere." The higher mean age of onset and the absence of a proximal tumour excess gives pause to consider the important differences that can be found between population based studies and those from tertiary referral centres. 6 7 We may have underestimated the prevalence of ' Deaths from cancer in first degree relatives (of the older probands) tended to be more accurately reported by index cases than deaths from noncancer causes, though this difference was not significant. The site of their relative's cancer (that is, the principle organ) was identified correctly by the index case in only 57% of cases. These proportions are very similar to those previously reported for the relatives of the 205 younger probands. 5 Twenty four relatives of the older probands and 68 relatives of the younger probands had colorectal cancer. Three of the older probands had two or more first degree relatives affected by bowel cancer as compared with 13 ofthe younger probands. In previous reports these families have been taken to represent probable Lynch syndrome pedigrees.
According to the site of the proband's original tumour (that is, either proximal or distal to the splenic flexure) there was no difference in the proportion ofcases with a verified positive family history of colorectal cancer in any first degree relative (Table II) . the contribution that these probands make to the overall tumour burden, it is probable that these families are at least as numerous in the community as those ascertained through early onset cases. Although the average age at onset in relatives of older probands was significantly greater than among the relatives of the younger cases, no study conducted at a single point in time can realistically assess a family's lifetime cancer risk. Nevertheless, our results are in keeping with those from two other large population based studies, each with a sample size of over 1500 index cases. 6 A characteristic age at onset among individuals carrying a supposed inherited susceptibility is not reliably estimated from the mean of affected individuals in a family, though this is how it has more usually been described. Identifying the high risk pedigrees (that are likely to benefit most from screening) is vital, but there remains much to be learned about the natural history of bowel cancer in these families. It might be salutary to conclude by echoing Lynch's own cautionary note: 'Needless to say it is difficult to be certain whether a homogeneous entity is being studied and difficult to determine what proportion of the study subjects at risk for hereditary non-polyposis colorectal cancer have a common familial or genetic susceptibility to adenoma formation unrelated to NHPCC. The interpretation of our results ... in patients with HNPCC was limited by an inability to obtain tissue from patients who were definitely affected by the disease. '20 they?
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